The molecular pathology of Barrett's esophagus

Histology and Histopathology

Volumn 14, Issue 2, 1999, Pages 553-559

  Werner, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Carcinoma; Dysplasia; Esophagus; Metaplasia; Molecular genetics

Indexed keywords

CADHERIN; CATENIN; KI 67 ANTIGEN;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DYSPLASIA; ESOPHAGUS CARCINOMA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; METAPLASIA; PRECANCER; REFLUX ESOPHAGITIS; REVIEW; TUMOR SUPPRESSOR GENE;

BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CELL DIVISION; CELL MEMBRANE; ENDOPEPTIDASES; GENES, TUMOR SUPPRESSOR; GROWTH SUBSTANCES; HUMANS; PLOIDIES; RECEPTORS, GROWTH FACTOR;

EID: 0032899598     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. al-Kasspooles M., Moore J.H., Orringer M.B. and Beer D.G. (1993). Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int. J. Cancer 54, 213-219.
2. Altorki N.K., Oliveria S. and Schrump D.S. (1997). Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin. Surg. Oncol. 13, 270-280.
3. Audrezet M.P., Robaszkiewicz M., Mercier B., Nousbaum J.B., Hardy E., Bail J.P., Volant A., Lozac'h P., Gouerou H. and Ferec C. (1996). Molecular analysis of the TP53 gene in Barrett's adenocarcinoma. Hum. Mutat. 7, 109-113.
4. Bailey T., Biddlestone L., Shepherd N., Barr H., Warner P. and Jankowski J. (1998). Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am. J. Pathol. 152, 135-144.
5. Barrett M.T., Galipeau P.C., Sanchez C.A., Emond M.J. and Reid B.J. (1996a). Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting whole genome amplification and microsatellite polymorphisms. Oncogene 12, 1873-1878.